Nemolizumab Rapidly Improves EASI, SCORAD Scores for Atopic Dermatitis; A post hoc analysis shows the investigative drug significantly improved atopic dermatitis symptoms versus placebo as soon as the first week into a phase 2 trial.

Press/Media

Period	23 Jun 2023

Media coverage

Title	Nemolizumab Rapidly Improves EASI, SCORAD Scores for Atopic Dermatitis; A post hoc analysis shows the investigative drug significantly improved atopic dermatitis symptoms versus placebo as soon as the first week into a phase 2 trial.
Media name/outlet	Consultant Live
Country/Territory	United States
Date	23/06/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=68M1-YJH1-JCXN-V11P-00000-00
Persons	Peter Lio